Synthesis of C2-symmetric and pseudosymmetric HIV-1 protease inhibitors from D-arabitol
- 31 December 1991
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 1 (4), 219-222
- https://doi.org/10.1016/s0960-894x(00)80256-5
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- An inhibitor of the protease blocks maturation of human and simian immunodeficiency viruses and spread of infection.Proceedings of the National Academy of Sciences, 1990
- Hydroxyethylamine analogs of the p17/p24 substrate cleavage site are tight-binding inhibitors of HIV proteaseJournal of Medicinal Chemistry, 1990
- Rational Design of Peptide-Based HIV Proteinase InhibitorsScience, 1990
- Substrate analog inhibition and active site titration of purified recombinant HIV-1 proteaseBiochemistry, 1990
- Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analoguesNature, 1990
- Inhibition of human immunodeficiency virus 1 protease in vitro: rational design of substrate analogue inhibitors.Proceedings of the National Academy of Sciences, 1989
- Conserved Folding in Retroviral Proteases: Crystal Structure of Synthetic HIV-1 ProteaseScience, 1989
- Human immunodeficiency virus 1 protease expressed in Escherichia coli behaves as a dimeric aspartic protease.Proceedings of the National Academy of Sciences, 1989
- Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1Nature, 1989
- Human immunodeficiency virus proteasePublished by Elsevier ,1989